Skip to main content

Table 2 Clinical features of liver dysfunction in the study groups

From: Effect of scheduled monitoring of liver function during anti-Tuberculosis treatment in a retrospective cohort in China

Clinical features

Scheduled monitoring group (n = 111)

Passive detection group (n = 162)

P value

Symptomatic liver dysfunction

20 (18.0%)

162 (100.0%)

<0.001

Liver dysfunction finding time, median, days (IQR)

52 (30, 61)

39 (28, 60)

0.205

Severity of liver dysfunction

Mild

70 (63.1%)

97 (59.9%)

0.443

Moderate

28 (25.2%)

37 (22.8%)

 

Severe

13 (11.7%)

28 (17.3%)

 

Requirement of hospitalization

2 (1.8%)

18 (11.1%)

0.004